Atara Biotherapeutics, Inc. (ATRA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.07M | -5.7M | -9.79M | -7.32M | -28.14M | -24.47M | -3.99M | -10.64M | -29.61M | -50.41M | -51.35M | -52.8M | -38.43M | -56.88M | -65.06M | -63.96M | -84.53M | -34.27M | -58.98M | -61.58M |
| Operating CF Margin % | -595.54% | -357.18% | -283.43% | -41.64% | -28.67% | -74.71% | -9.93% | -37.17% | -108.24% | -1185.47% | -2401.59% | -5516.82% | -3134.5% | -25737.56% | -1459% | -124.01% | -1155.72% | -454.01% | -1098.29% | -1591.14% |
| Operating CF Growth % | 89.08% | 76.72% | -145.35% | 31.25% | 4.98% | 51.45% | 92.23% | 79.84% | 22.94% | 11.38% | 21.08% | 17.46% | 54.54% | -65.98% | -10.31% | -3.88% | -28.66% | -731.77% | -11.37% | -8.72% |
| Net Income | -4.14M | -3.41M | -4.3M | 2.39M | 38.01M | -12.69M | -21.91M | -19.05M | -31.75M | -60.45M | -69.8M | -71.11M | -74.77M | -74.57M | -84.09M | 18.47M | -88.11M | -93.35M | -84.66M | -83.79M |
| Depreciation & Amortization | 29K | -126K | 36K | 236K | 1.79M | 1.1M | 1.23M | 1.33M | 1.39M | 1.21M | 1.21M | 1.2M | 1.21M | 1.25M | 4.14M | 1.44M | 1.59M | 2.49M | 2.32M | 2.32M |
| Stock-Based Compensation | 0 | 1.52M | 1.23M | 2.8M | 4.21M | 5.85M | 6.42M | 6.34M | 8.4M | 9.93M | 11.14M | 12.55M | 11.76M | 11.36M | 0 | 14.12M | 14.34M | 14.03M | 13.76M | 13.81M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.8M | 78.43M | 1.13M | 29K | 9.96M | 3.68M | 3.71M | 4.12M | 4.08M | 6.19M | 4.13M | 3.46M | 3.81M | 2.94M | 14.19M | -47.16M | 1.13M | 1.24M | 941K | 895K |
| Working Capital Changes | -754K | -82.11M | -7.88M | -12.77M | -82.11M | -22.41M | 6.56M | -3.38M | -11.73M | -7.28M | 1.97M | 1.09M | 19.55M | 2.13M | 707K | -50.83M | -13.48M | 41.33M | 8.67M | 5.2M |
| Change in Receivables | 1.25M | 660K | -1.91M | 8.88M | -7.39M | -147K | 1.09M | 33.41M | -1.73M | -33.95M | 344K | -110K | 39.82M | -39.97M | 388K | 31K | 318K | -986K | 0 | 9.61M |
| Change in Inventory | 0 | 0 | 0 | 0 | 10.65M | -160K | 4.77M | -2.67M | -6.38M | -3.12M | 1.27M | -2.52M | -3.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 510K | -191K | -983K | -83K | -2.98M | 2.22M | -3.11M | 2.4M | -826K | -2.81M | 2.46M | -894K | -1.89M | -4.45M | -1.38M | 1.2M | -4.59M | 357K | 4.35M | -5.2M |
| Cash from Investing | 0 | 8.44M | -2.42M | -5.07M | 17.2M | 3.38M | -16.66M | 7.2M | 14.72M | 9.94M | 70.45M | 49.48M | -6.01M | 51.22M | 59.7M | 31.83M | 60.22M | -24.32M | 1.19M | 31.89M |
| Capital Expenditures | 0 | 0 | 0 | 349K | 0 | -90K | 0 | -29K | -127K | -44K | -281K | -499K | -399K | -37K | -132K | -1.42M | -2.6M | -2.47M | -3.86M | -2.06M |
| CapEx % of Revenue | - | - | - | 1.99% | - | 0.27% | - | 0.1% | 0.46% | 1.03% | 13.14% | 52.14% | 32.54% | 16.74% | 2.96% | 2.75% | 35.62% | 32.67% | 71.81% | 53.26% |
| Acquisitions | 0 | 0 | 44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 555K | 0 | -5.42M | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 0 | 0 | 0 | 0 | 94.77M | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.95M | -3K | 1.05M | 15.3M | -250K | -328K | 35.79M | -324K | 24.14M | 1.51M | -208K | 471K | 235K | 32.29M | -214K | 1.16M | 19.85M | 51.47M | 47.14M | 2.45M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -250K | -235K | -197K | -233K | -227K | -215K | -208K | -212K | -312K | -122K | -206K | -126K | -64K | -62K | -62K | -64K |
| Equity Issued (Net) | 2.95M | 0 | 1.03M | 0 | 0 | -210K | 50.81M | -15.03M | 24.37M | 1.55M | 0 | -50K | 640K | 31.98M | 47K | -23K | 20.54M | 49.96M | 46.36M | -75K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -3K | 12K | 15.3M | 0 | 117K | -14.82M | 14.94M | -6K | 181K | 0 | 733K | -93K | 432K | -55K | 1.31M | -624K | 1.57M | 842K | 2.59M |
| Net Change in Cash | -122K | 2.74M | -11.16M | 2.92M | -11.19M | -21.42M | 15.14M | -3.77M | 9.25M | -38.95M | 18.89M | -2.84M | -44.2M | 26.63M | -5.57M | -30.98M | -4.46M | -7.13M | -10.65M | -27.24M |
| Free Cash Flow | -3.07M | -5.7M | -9.79M | -7.32M | -28.14M | -24.56M | -3.99M | -10.67M | -29.74M | -50.45M | -51.63M | -53.3M | -38.83M | -56.92M | -65.19M | -65.38M | -87.13M | -36.73M | -62.83M | -63.64M |
| FCF Margin % | -595.54% | -357.18% | -283.43% | -41.64% | -28.67% | -74.99% | -9.93% | -37.27% | -108.71% | -1186.5% | -2414.73% | -5568.97% | -3167.05% | -25754.3% | -1461.96% | -126.76% | -1191.33% | -486.69% | -1170.09% | -1644.39% |
| FCF Growth % | 89.08% | 76.8% | -145.35% | 31.44% | 5.38% | 51.32% | 92.27% | 79.97% | 23.41% | 11.36% | 20.8% | 18.49% | 55.44% | -54.94% | -3.75% | -2.74% | -28.34% | -678.12% | -17.53% | -8.39% |
| FCF per Share | -0.22 | -0.45 | -0.72 | -0.59 | -2.59 | -2.30 | -0.53 | -1.74 | -5.29 | -11.66 | -12.13 | -12.68 | -9.34 | -13.79 | -15.91 | -16.05 | -21.63 | -9.43 | -16.78 | -17.26 |
| FCF Conversion (FCF/Net Income) | 0.74x | 1.67x | 2.27x | -3.07x | -0.74x | 1.93x | 0.18x | 0.56x | 0.93x | 0.83x | 0.74x | 0.74x | 0.51x | 0.76x | 0.77x | -3.46x | 0.96x | 0.37x | 0.70x | 0.73x |
| Interest Paid | 0 | 0 | 53K | 52K | 66K | 188K | 138K | 245K | 114K | 115K | 114K | 106K | 112K | 79K | 0 | 128K | 5K | 7K | 7K | 8K |
| Taxes Paid | 0 | 0 | 28K | 3K | 0 | 0 | 0 | 0 | 24K | 0 | 0 | 1K | 1K | 0 | 0 | 5K | 14K | -1K | 9K | -1K |